Erlotinib 150mg Tablets Exporters

* To be consumed as directed by physician.

Erlotinib 150mg Tablets

Erlotinib (150mg)
Erlotinib tablets is a non-chemotherapy drug that belongs to the group of medicines called Cytostatic agents. It is Epidermal Growth Factor Receptor-Kinase Inhibitor (EGFR-TKI). The medicine binds tyrosine kinase (the intracellular) portion of protein called epidermal growth factor receptor and inhibits the spread or growth of cancer cells in the body.
  • It treats advanced, unresectable metastatic pancreatic cancer and non-small cell lung cancer (NSCLC) in adult patients.
  • It is used to treat pancreatic cancer.
  • It is used to treat advanced mNSLC after the failure of one prior chemotherapy regimen.
  • Patients with both metastatic and advanced non-small lung cancer can take Erlotinib tablets in combination with gemcitabine as initial choice of treatment.
  • Erlotinib is prescribed to the patients with tumors when all the other options of treatments fail or found not suitable.
  • Try and observe the changes in your body after taking the medicine and immediately consult your doctor for treatment before they get worse and bother your health.
  • Tell your doctor if you are allergic to the medicine or have any specific allergies and have medical history of heart, lung, and kidney diseases and already taking any medications.
  • Avoid eating grapes or grape juices while taking this tablet.
(4.1 Rating)

Product Enquiry

Send Message